# Lactate Imaging as a Tumour Biomarker

> **NCT01881386** · — · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 37 (actual)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** Magnetic Resonance Imaging (MRI)

## Key facts

- **NCT ID:** NCT01881386
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-01
- **Primary completion:** 2017-09-01
- **Final completion:** 2017-09-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01881386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01881386, "Lactate Imaging as a Tumour Biomarker". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01881386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*